News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Skyepharma PLC (SKYE) Takes Over US Flutiform NDA From Abbott Laboratories (ABT)


2/5/2010 11:04:49 AM

Bookmark and Share

IB Times -- The US New Drug Application for asthma drug Flutiform is being transferred to SkyePharma. Last month the US Food and Drug Administration rebuffed the NDA and said there were "substantive" issues that needed to be resolved ahead of an approval. SkyePharma believes the transfer of the NDA will enable it to deal directly with the FDA in these discussions.

Read at News Release
Read at RTT News
Read at Wall Street Journal


comments powered by Disqus
   
Asthma

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES